key: cord-0833232-wiei5dpt authors: Wilson, N. M.; Marks, G. B.; Eckhardt, A.; Clarke, A. M.; Young, F. P.; Garden, F. L.; Stewart, W.; Cook, T. M.; Tovey, E. R. title: The effect of respiratory activity, non‐invasive respiratory support and facemasks on aerosol generation and its relevance to COVID‐19 date: 2021-03-30 journal: Anaesthesia DOI: 10.1111/anae.15475 sha: 23362d3cdf930bdba107d3fc60ac7d7b4378842b doc_id: 833232 cord_uid: wiei5dpt Respirable aerosols (< 5 µm in diameter) present a high risk of SARS‐CoV‐2 transmission. Guidelines recommend using aerosol precautions during aerosol‐generating procedures, and droplet (> 5 µm) precautions at other times. However, emerging evidence indicates respiratory activities may be a more important source of aerosols than clinical procedures such as tracheal intubation. We aimed to measure the size, total number and volume of all human aerosols exhaled during respiratory activities and therapies. We used a novel chamber with an optical particle counter sampling at 100 l.min(‐1) to count and size‐fractionate close to all exhaled particles (0.5–25 µm). We compared emissions from ten healthy subjects during six respiratory activities (quiet breathing; talking; shouting; forced expiratory manoeuvres; exercise; and coughing) with three respiratory therapies (high‐flow nasal oxygen and single or dual circuit non‐invasive positive pressure ventilation). Activities were repeated while wearing facemasks. When compared with quiet breathing, exertional respiratory activities increased particle counts 34.6‐fold during talking and 370.8‐fold during coughing (p < 0.001). High‐flow nasal oxygen 60 at l.min(‐1) increased particle counts 2.3‐fold (p = 0.031) during quiet breathing. Single and dual circuit non‐invasive respiratory therapy at 25/10 cm.H(2)O with quiet breathing increased counts by 2.6‐fold and 7.8‐fold, respectively (both p < 0.001). During exertional activities, respiratory therapies and facemasks reduced emissions compared with activities alone. Respiratory activities (including exertional breathing and coughing) which mimic respiratory patterns during illness generate substantially more aerosols than non‐invasive respiratory therapies, which conversely can reduce total emissions. We argue the risk of aerosol exposure is underappreciated and warrants widespread, targeted interventions. Infection with SARS-CoV-2 and consequent COVID-19 are a significant cause of mortality and morbidity among patients, healthcare workers and the general population [1, 2] . Many international COVID-19 guidelines state that SARS-CoV-2 transmission is primarily through larger respiratory fluid 'droplets' (> 5 µm diameter), while aerosols (< 5 µm) are only of significant risk during aerosol-generating procedures [3, 4] . Therefore, standard protection against COVID-19 is based on preventing droplet transmission, which includes surgical facemasks, whereas, fit-tested N95/ FFP3 respirators and enhanced environmental ventilation are recommended only during aerosol-generating procedures [3, 4] . Aerosols are of concern as they may: contain replication-competent virus; travel on airflows; better evade surgical masks; and deposit on the alveolar epithelium, potentially increasing disease severity [5] [6] [7] [8] [9] . Concerningly, a higher prevalence of infection has been observed in healthcare workers caring for COVID-19 patients using droplet compared with aerosol measures [10] [11] [12] . The special status accorded to aerosol-generating procedures is based on weak epidemiological evidence from the severe acute respiratory syndrome (SARS) 2003 epidemic, where increased disease transmission occurred in healthcare workers exposed to patients requiring acute respiratory therapies [13] . Aerosols were not measured in these studies [13] . Respiratory therapies such as high-flow nasal oxygen (HFNO) and non-invasive positive pressure ventilation (NIPPV) are universally designated as aerosol-generating procedures [14] . However, these therapies may suppress aerosol emissions by altering pulmonary mechanics or filtering exhaled gases [15] . Earlier studies quantifying aerosols during therapies suggest both increased and decreased emissions [16] [17] [18] [19] . A recent study [20] Supporting Information Appendix S1. Sample size was based on pilot data obtained during protocol development and previous studies [24] . As particle counts were skewed positively, the counts were logtransformed before analysis. Hygrometer, thermomete Figure 1 The sampling chamber consists of a rear section containing filters, which supplies clean air through a wall composed of air-filter media, and a clear-walled forward section which accommodates the torso of the subject. A flexible non-porous skirt allows entry of the subject and the tubing of non-invasive devices. The subject's head is positioned within a cut-away section of a large cone, which is attached to an optical particle counter, sampling at 100 l.min -1 and mounted outside the chamber. Airflow in the 100-mm diameter tube at the distal end in the chamber is monitored via an anemometer probe. Humidity and temperature were monitored using a hygrometer and thermometer positioned in front of the subject, on the chamber floor. A moveable pedal exerciser was mounted so the subject could exercise in their seated position. the geometric means of activities and/or therapy with 95% CIs. Particle counts in the six size bins were transformed to estimated particle volumes using the formula, volume = 4/ 3 9 p 9 radius 3 . Further details of data analysis and volume conversion are provided in online Supporting Information Table S2 . The respiratory fluid particles between 0. 5 Table S5 ). The three respiratory therapies showed slight increases in total particle counts at higher flows and pressures ( Fig. S1 ). The effect of surgical facemasks varied with activity, generally decreasing total emissions with apparent larger reductions observed in activities with higher particle counts (Table 1, online Supporting Information Fig. S1 ). The 1.2-fold increase in emissions wearing a mask during quiet breathing was not significant (p = 0.616). The majority (> 92%) of particles produced (by number) across all activities and procedures were respirable aerosols (≤ 5 µm) (Fig. 3 , online Supporting Information Table S5 ). The proportion of the total volume of particles that were aerosols ranged between 5.9% and 34.9% for all respiratory activities alone, with coughing producing the greatest proportion, and between 7.1% and 22.4% during HFNO and NIPPV with quiet breathing (Figure 3 , online Supporting Information Table S5 and S6). The intraclass correlation of subjects for all activities with and without devices was 0.065 and 0.068, respectively, indicating substantial variation between subjects in the total number of exhaled particles and the effect of activities and respiratory therapies. Although breathing was consistently a minor contributor to the total volume of particles, the ranking of other activities varied between subjects (online Supporting Information Fig. S2 ). The removal of the highest contributor had negligible effect on the relative magnitude of changes in particle emissions between activities and therapies (online Supporting Information Table S7 ). The qualitative viewing of exhaled e-cigarette aerosols is illustrated in online Supporting Information Fig. S3 and Video S1. This suggests minor incomplete sampling may have occurred with all activities and substantial undersampling during coughing, FEVs and wearing of surgical masks. The assessment of ventilator performance demonstrated NIPPV-D was associated with 30% more asynchronous respiratory cycles than NIPPV-S (online Supporting Information Table S8 ). This study is the first to explore near-complete exhaled These and other recent studies to quantify respiratory aerosols have collected particles at a short distance from the Table 1 Fold changes in average total particle counts (geometric mean per size bin) relative to reference activity using log particle counts. Respiratory ac vi es Respiratory therapies at maximal se ngs Figure 2 The total number of exhaled respiratory particles sampled from ten subjects. Samples were measured over a period of 1 min during six respiratory activities and when breathing quietly while three respiratory therapies, designated as aerosolgenerating procedures, were applied. The therapies were high-flow nasal oxygen (HFNO) and non-invasive positive pressure ventilation with a single (NIPPV-S) or dual (NIPPV-D) circuit. All respiratory therapies shown were recorded at the highest settings used: HFNO at a flow of 60 l.min -1 and both NIPPV-S and NIPPV-D at inspiratory/expiratory airway pressures of 25/10 cm.H 2 O. The geometric mean and upper and lower 95% confidence intervals are shown by the black bars ( ). The size range in the six particle bins as measured by the optical particle counter are: 10-25 µm (light blue); 5-10 µm (orange); 3-5 µm (grey); 1-3 µm (green); 0.7-1 µm (yellow); and 0.5-0.7 µm (dark blue). A value of 0.3 was added to all counts to facilitate analysis after log transformation, so zero particle counts are shown as 0.3. Overlapping dot points are not shown. Both the forced expiratory volume (FEV) manoeuvre and cough were repeated six times in the sampling min. pressure changes required to breath efficiently, may reduce aerosols [15, 35, 36] . The inclusion of exercise and forced expiratory manoeuvres, as proxies for symptomatic laboured breathing and atelectasis, suggests an aerosolsuppressing role for such therapies in patients with respiratory distress. Total aerosol emissions during noninvasive respiratory therapy reflect a balance between the aerosol-generating effects of gas flow and pressure detectable during quiet breathing, and aerosolsuppressing effects which predominate during exertional respiratory activities. When a surgical mask was worn, the apparent filtration increased during higher velocity activities. However, our video study suggests this was partly due to masks deflecting gas away from the collecting cone. This is consistent with other studies showing sideways leakage with surgical masks [39, 40] . While this deflection may blunt the forward plume and remove large droplets, reducing direct person-toperson exposure, aerosols could still accumulate in poorly ventilated spaces [15] . Our study's strengths are that we were able to There are several limitations to our study. We recruited 10 healthy subjects who performed a single protocol run. There may have been some differences in how subjects performed activities, which may contribute to the previously observed wide inter-subject variation [25, 29] . We estimated the average residence time for particles in the cone should have been sufficient for them to reach equilibrium diameter [41] . [3, 4] . In summary, our data add to a small but growing number of quantitative studies that challenge the rationale for describing certain respiratory therapies as aerosolgenerating procedures [17] [18] [19] [20] . Patients acutely requiring HFNO or NIPPV are likely to present a high disease transmission risk due to their propensity to produce aerosols, but we find no basis for withholding or delaying access to these therapies. We conclude instead that exertional respiratory activities themselves are the primary modes of aerosol generation and represent a greater transmission risk than is widely recognised currently. Therefore, increased measures targeting physiologically generated aerosols could protect patients, healthcare workers and the public from respiratory pathogens, including SARS-CoV-2. Figure S2 . Total volumes of particles generated by six different activities by each subject. Figure S3 .1-3.10. Series of photographs from Video S1 to illustrate specific exhaled gas sampling behaviour. Table S1 . Activities are shown in columns and devices in rows. Table S2 . Particle size to volume conversion table used to convert particle number to particle volume. Table S3 . Subject baseline demographic data. Table S4 . Recordings of temperature and relative humidity from within the chamber during the title experiment. Table S5 . The distribution of particle number and total sum of particle volumes. with quiet breath, for all subjects (n = 10) and with the subject contributing highest emission is removed (n = 9). Video S1. Study establishing exhaled gas sampling efficiency during different respiratory therapies and activities using replica apparatus. Appendix S1. Further description of the methods used for these experiments. Mapping health worker deaths from COVID-19 The ongoing problem of UK hospital acquired infections -the centre for evidence-based medicine. The Centre for Evidence-Based Medicine -University of Oxford Scientific brief. Transmission of SARS-CoV-2: implications for infection prevention precautions COVID-19: infection prevention and control (IPC) Particle sizes of infectious aerosols: implications for infection control Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards Recognition of aerosol transmission of infectious agents: a commentary The flow physics of COVID-19 COVID-2019) infection among Health care workers and implications for prevention measures in a tertiary hospital in Wuhan Spinal anaesthesia for patients with coronavirus disease 2019 and possible transmission rates in anaesthetists: retrospective, single-centre, observational cohort study Occupational COVID-19 risk for anaesthesia and intensive care staff -low-risk specialties in a high-risk setting Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review Classification of aerosolgenerating procedures: a rapid systematic review Airborne transmission of severe acute respiratory syndrome coronavirus-2 to healthcare workers: a narrative review Aerosolisation during tracheal intubation and extubation in an operating theatre setting Influenza aerosols in UK hospitals during the H1N1 (2009) pandemic -the risk of aerosol generation during medical procedures A quantitative evaluation of aerosol generation during tracheal intubation and extubation Assessment of dispersion of airborne particles of oral/nasal fluid by high flow nasal cannula therapy Aerosol generation from the respiratory tract with various modes of oxygen delivery Consensus guidelines for managing the airway in patients with COVID-19: Guidelines from the Difficult Airway Society, the Association of Anaesthetists the Intensive Care Society, the Faculty of Intensive Care Medicine and the Royal College of Anaesthetist Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities The effect of exhalation flow on endogenous particle emission and phospholipid composition Aerosol emission and superemission during human speech increase with voice loudness Exhaled particles and small airways The mechanism of breath aerosol formation Comparing aerosol concentrations and particle size distributions generated by singing, speaking and breathing. Aerosol Science and Technology Exhaled particles after a standardized breathing maneuver Effect of airway opening on production of exhaled particles Modality of human expired aerosol size distributions Study on the initial velocity distribution of exhaled air from coughing and speaking The shouted voice: a pilot study of laryngeal physiology under extreme aerodynamic pressure Flow dynamics and characterization of a cough Use of nasal high flow oxygen during acute respiratory failure Non-invasive ventilation in acute respiratory failure Patient-ventilator interaction during noninvasive ventilation Mask mechanics and leak dynamics during noninvasive pressure support ventilation: a bench study Visualizing the effectiveness of face masks in obstructing respiratory jets A schlieren optical study of the human cough with and without wearing masks for aerosol infection control Toward understanding the risk of secondary airborne infection: emission of respirable pathogens This study was supported by a Prince of Wales Hospital Additional supporting information may be found online via the journal website.